MitraClip device for patients at moderate risk for surgery

Trial ID:
Matthew J Price, M.D.
The purpose of this research is to extend the current approved indication of the MitraClip device to include patients who are considered moderate-risk candidates for traditional mitral valve repair surgery.
*Must be 18 years old or older<br>*Must be at moderate surgical risk for mitral valve repair<br>*Must have severe mitral regurgitation<br>*Be willing to participate in the trial for 10 years<br>

Contact Info:

  • Clinical Research Services